pre-IPO PHARMA

COMPANY OVERVIEW

ImmunOs Therapeutics AG is a biotechnology company active in the discovery and development of the next generation of novel human immunomodulatory proteins focused on innate immunity. Originally a spin-off company of the University of Zurich and the University of Basel, our mission is to develop novel therapeutics that will improve the lives of patients with serious disease. ImmunOs Therapeutics AG lead program is a next generation, novel platform of multitasking biologics targeting diverse immunoregulatory receptors that activate anti-tumor responses built upon years of research and development. ImmunOs proteins work directly on the innate immune system.


LOCATION

  • Schlieren, , Switzerland

  • THERAPEUTIC AREAS

  • Autoimmune Disease
  • Oncology

  • WEBSITE

    https://www.immunostherapeutics.com


    CAREER WEBSITE

    https://www.immunostherapeutics.com/careers.html


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Jun 7, 2022

    ImmunOs Therapeutics Raises $74 Million Series B Financing Round


    Dec 10, 2019

    ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer Into Human Trials


    For More Press Releases


    Google Analytics Alternative